An interventional study of Exercise in Prostate Cancer, sponsored by Massachusetts General Hospital. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-17.
Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 32 studies in Prostatic Neoplasms by Massachusetts General Hospital — 4 open to participants now, 5 under way, none of them phase 3. Prostatic Neoplasms · Massachusetts General Hospital.
Among the 32 studies in Prostatic Neoplasms by Massachusetts General Hospital, this one is the 14th largest by planned enrollment of the 20 interventional ones that give a count, is the only one that started in 2026, is one of 7 with no phase, and was the 32nd registered.
7,055 studies on the registry are indexed under Prostatic Neoplasms; 1,582 are open to participants now.
Browse Prostatic Neoplasms studies →4 of the 32 studies in Prostatic Neoplasms by Massachusetts General Hospital are open now, in 1 country. Recruiting first, the newest first:
Massachusetts General Hospital · Sites in United States
Ages 18+ · Men only
Massachusetts General Hospital · Sites in United States
Ages 35+ · Men only
Massachusetts General Hospital · Sites in United States
Ages 18+ · Men only
By country, each count listing its studies:
Of the 1,236 Prostatic Neoplasms studies recruiting now, 933 (75%) set no upper age limit and 77 (6%) stop at 75 or younger; 67 take children under 18; 82 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
32 studies; the count open now beside each. This study's row is marked.
First in 2000; this study’s year is marked. 1 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 20 is below the median of 60 across 5,358 interventional studies indexed under Prostatic Neoplasms.
Median enrollment 35 across the 20 interventional studies, 55 across the 12 observational. Of the 24 that completed or were terminated, 10 (42%) have results posted.
This tab as a report to print or save as PDF → With an account.
Massachusetts General Hospital is the lead sponsor of 2,591 studies on the registry; 445 are open to participants now.
Of its 224 completed or terminated interventional studies of FDA-regulated products, 168 (75%) have results posted.
2 of the studies in Prostatic Neoplasms by Massachusetts General Hospital that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT01961713Massachusetts General HospitalCirculating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy | 2026-12-31 |
| NCT07768917Massachusetts General HospitalTraining on Systemic and Organ Spec. PM in PC | 2027-01-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 32 studies in Prostatic Neoplasms by Massachusetts General Hospital, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This research is being done to assess the impact of a supervised and structured strength and conditioning program on cardiac remodeling in participants with prostate cancer undergoing treatment with external beam radiation therapy and at least 6 months of Gonadotropin-releasing hormone (GnRH) therapy.
This study is designed to determine the impact of a strength and conditioning program on cardiac remodeling in participants with prostate cancer undergoing treatment with external beam radiation therapy and at least 6 months of Gonadotropin-releasing hormone (GnRH) therapy. In this study the participants will complete an exercise program that includes structured strength and conditioning programs which may include weightlifting, running, cycling, and stretching. During the research study participants will have data collected and blood samples taken which will be used to evaluate the prevention and reduction of potential harms induced by prostate cancer treatment. Participants will be in this research for 7 months which includes 6-months of the exercise intervention along with 1-month post-intervention activities. It is expected that about 20 people will take part in this research study.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The diagnosis was confirmed by looking at a sample under a microscope: tissue from a biopsy or surgery (histology), or cells from a fluid or needle sample (cytology).
Your pathology report is the document that shows this.
A scale of how much an illness limits everyday activity. For people being assessed to join a study, scores run from 0 (fully active) to 4; lower is more active.
Studies most often ask for 0–1 or 0–2. Your doctor gives the score; the WHO scale uses the same steps. The full scale also has 5, which records death.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Histologically or cytologically confirmed
The diagnosis was confirmed by looking at a sample under a microscope: tissue from a biopsy or surgery (histology), or cells from a fluid or needle sample (cytology).
Your pathology report is the document that shows this.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ECOG performance status
A scale of how much an illness limits everyday activity. For people being assessed to join a study, scores run from 0 (fully active) to 4; lower is more active.
Studies most often ask for 0–1 or 0–2. Your doctor gives the score; the WHO scale uses the same steps. The full scale also has 5, which records death.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will undergo a 6-month exercise program.
Other: Exercise
Supervised and structured strength and conditioning program
Left Ventricular Ejection Fraction
Left ventricular ejection fraction (%) as measured by echocardiogram
Time frame: At the start of the exercise program for up to 6 month after exercise program.
Left Ventricular Mass
Left ventricular mass (g) as measured by echocardiogram
Time frame: Time Frame: At the start of the exercise program for up to 6 month after exercise program.
Left Ventricular Mass Index (g/m2)
Left ventricular mass index (g/m2) as measured by echocardiogram
Time frame: Time Frame: At the start of the exercise program for up to 6 month after exercise program.
Posterior cardiac wall thickness (mm)
Posterior cardiac wall thickness (mm) as measured by echocardiogram.
Time frame: Time Frame: At the start of the exercise program for up to 6 month after exercise program.
Relative cardiac wall thickness (ratio)
Relative cardiac wall thickness (ratio) as measured by echocardiogram
Time frame: Time Frame: At the start of the exercise program for up to 6 month after exercise program.
Left ventricular end-diastolic and end-systolic dimension (mm)
Left ventricular end-diastolic and end-systolic dimension (mm) as measured by echocardiogram.
Time frame: Time Frame: At the start of the exercise program for up to 6 month after exercise program.
Cardiac output (L/min)
Cardiac output (L/min) as measured by echocardiogram.
Time frame: Time Frame: At the start of the exercise program for up to 6 month after exercise program.
Heart rate (bpm)
Heart rate (bpm) as measured by Cardiopulmonary Exercise Testing
Time frame: Time Frame: At the start of the exercise program for up to 6 month after exercise program.
Blood pressure, systolic and diastolic (mmHg)
Blood pressure, systolic and diastolic (mmHg) as measured at Cardiopulmonary Exercise Testing
Time frame: Time Frame: At the start of the exercise program for up to 6 month after exercise program.
VO2max (mL/kg/min)
VO2max (mL/kg/min) as measured on Cardiopulmonary Exercise Testing
Time frame: Time Frame: At the start of the exercise program for up to 6 month after exercise program.
C-reactive protein (mg/L)
C-reactive protein (mg/L) measured by blood draw
Time frame: Time Frame: At the start of the exercise program for up to 1 month after exercise program.
Erythrocyte sedimentation rate (mm/hr)
Erythrocyte sedimentation rate (mm/hr) measured by blood draw
Time frame: Time Frame: At the start of the exercise program for up to 1 month after exercise program.
Neutrophil lymphocyte ratio (ratio)
Neutrophil lymphocyte ratio (ratio) as measured from blood draw values
Time frame: Time Frame: At the start of the exercise program for up to 1 month after exercise program.
Systemic immune-inflammation index (SII)
Systemic immune-inflammation index (SII) as derived from blood draw values
Time frame: Time Frame: At the start of the exercise program for up to 1 month after exercise program.
Hand grip strength (kg)
Hand grip strength (kg) measured by dynamometer
Time frame: Time Frame: At the start of the exercise program for up to 1 month after exercise program.
Timed up and go test (seconds)
Timed up and go test (seconds) measured by stopwatch during exercise testing.
Time frame: Time Frame: At the start of the exercise program for up to 1 month after exercise program.
Fatigue and health related quality of life (SF-36 questionnaire)
Fatigue and health related quality of life (SF-36 questionnaire) measured by standardized patient questionnaire.
Time frame: Time Frame: At the start of the exercise program for up to 1 month after exercise program.
Plan to share: Yes — The Dana-Farber / Harvard Cancer Center encourages and supports the responsible and ethical sharing of data from clinical trials. De-identified participant data from the final research dataset used in the published manuscript may only be shared under the terms of a Data Use Agreement. Request may be directed to Peter Lee, MD, PhD. The protocol and statistical analysis plan will be made available on ClinicalTrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
Time frame: Data can be shared no earlier than 1 year following the date of publication
Access criteria: Contact the Partners Innovations team at http://www.partners.org/innovation
No publications or documents are linked to this record.
Start is estimated for Dec 2026; primary completion for Jan 2027, 1 month later.
Of 1,104 non-industry interventional studies with no phase under Prostatic Neoplasms, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 87. This study's planned 1 month is below that.
Counting every sponsor, half of 1,162 studies reached it within 43 months; a quarter within 22 and three quarters within 86.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Massachusetts General Hospital →